Cost-Effectiveness of Nivolumab (NIVO) Combined with Ipilimumab (IPI) Compared with Nivo and Ipi Monotherapies in The First-Line Treatment of Advanced Melanoma in The United States- Analysis Using 28-Month Overall Survival (OS) Data from Ch ...

Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.218
https://www.valueinhealthjournal.com/article/S1098-3015(17)30552-1/fulltext
Section Title : Disease-Specific Studies
Section Order : 199
First Page : A436
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30552-1&doi=10.1016/j.jval.2017.08.218
HEOR Topics :
Tags :
Regions :